ArticleThe Journal of infection2023

Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study.

Andrew Evans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.